NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-091-2009-0-CA-04 Anti-Mesothelin Antibodies CA National Stage 2756393 Abandoned
NCI E-091-2009-0-AU-03 Anti-Mesothelin Antibodies AU National Stage 2010230063 Abandoned
NCI E-091-2009-0-US-06 ANTI-MESOTHELIN ANTIBODIES (HN1) US National Stage 13/259,138 8460660 Issued PDF
NCI E-091-2009-0-PCT-02 Anti-Mesothelin Antibodies PCT PCT PCT/US10/28336 Expired
NCI E-091-2009-0-EP-05 Anti-Mesothelin Antibodies EP National Stage 10722212.7 Abandoned
NCATS E-252-2009-1-US-01 Discovery Of Potent And Selective Inhibitors Of 15-1 Human Lipoxygenase US 61/315,788 Abandoned
NIDDK E-125-2010-0-US-01 Nicotinic Acetylcholine Receptor Agonists US 61/315,674 Abandoned
NCI E-019-2010-0-US-01 Novel Nitroxyl (HNO) Prodrugs And Biomedical Applications Thereof US 61/315,604 Abandoned
NIAID E-148-2009-2-US-02 Use Of Ixolaris, A Tissue Factor (anticoagulant) Inhibitor, For The Treatment Of Cancer US National Stage 13/257,455 8772238 Issued PDF
NIAID E-148-2009-2-PCT-01 Use Of Ixolaris, A Tissue Factor (anticoagulant) Inhibitor, For The Treatment Of Cancer PCT PCT COMB PCT/US2010/027797 Expired
NIDDK E-109-2009-0-PCT-02 Inhibitors of Viral Integrase and Methods of Use PCT PCT PCT/US2010/027870 Expired
NIDDK E-109-2009-0-EP-05 Inhibitors of Viral Integrase and Methods of Use EP National Stage 10754135.1 Abandoned
NCI E-046-2004-0-EP-13 Mutated anti-CD22 Anitbodies and Immunoconjugates EP DIV 10156976.2 Abandoned
NIDDK E-109-2009-0-JP-06 Inhibitors of Viral Integrase and Methods of Use JP National Stage 2012-500974 Abandoned
NIDDK E-109-2009-0-AU-03 Inhibitors of Viral Integrase and Methods of Use AU National Stage 2010226541 Abandoned
NIDDK E-109-2009-0-CN-10 Inhibitors of Viral Integrase and Methods of Use CN National Stage 201080012573.6 Abandoned
NIDDK E-109-2009-0-CA-04 Inhibitors of Viral Integrase and Methods of Use CA National Stage 2755866 Abandoned
NHLBI E-028-2008-0-US-03 Methods Of Treatment For Hemolysis US National Stage 12/678,539 8980871 Issued PDF
NCI E-254-1999-0-US-05 New Tumor Suppressor Gene, p47ING3 US DIV 12/724,305 8067563 Abandoned PDF
NIDDK E-049-2010-1-US-01 (N)-Methanocarba Adenosine Derivatives And Their Dendrimer Conjugates As A3 Receptor Agonists US 61/313,961 Abandoned
NCI E-048-2010-0-US-01 Improved Pepper Spray For Repellency And Incapacitation Of People And Animals US 61/340,063 Abandoned
NCI E-003-2010-0-US-01 Modified POTE Peplide Vaccine Againsl Cancer Of The Prostate, Colon, Lung, Breast, Ovary And Pancreas US 61/313,559 Abandoned
NCI E-034-2010-0-US-01 A New Type of GlycolipId Antigen Stimulating NKT Cells to Induce Anti-Tumor Immunity US 61/313,508 Abandoned
NCI E-082-2004-2-AU-08 Methods of Preventing or Treating T Cell Malignancies by Adminstering CD2 Antagonists AU DIV 2010200956 Abandoned
NCATS E-286-2011-0-US-01 Compounds As RORgammat Modulators And Uses Thereof US 61/339,996 Abandoned
NHLBI E-057-2010-0-US-01 RELEASIBLE SNAP-TAG LIGANDS AND METHODS OF MAKING AND
USING SAME 		US 61/312,814 Abandoned
NCATS E-235-2010-0-US-01 HETEROCYCLIC COMPOUNDS AS RORyt MODULATORS AND USES THEREOF US 61/339,974 Abandoned
NIDCR E-015-2002-1-US-07 Mammalians Sweet Taste receptors US CON 12/721,463 8198048 Expired PDF
NIDCR E-036-2010-0-US-01 Composition and Mehtods for Screening for Lyme Diseasee US 61/312,520 Abandoned
NIA E-013-2010-0-US-01 THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS US 61/312,642 Abandoned
NCI E-106-2003-0-CA-04 Griffithsin, Glycosylation-Resistant Griffithsin, and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production And Methods of Use CA National Stage 2567728 Expired
NHLBI E-141-2009-0-PCT-02 Magnetic Resonance Imaging Method And Apparatus For High-Resolution Spatia I And Temporal Data- Driven Reconstructions ("Self-Navigation" Or "Self-Gating) PCT PCT PCT/US2010/026666 Expired
NIDCR E-066-1996-0-US-09 AAV4 VECTOR AND USES THEREOF US CON 12/719,671 8507267 Abandoned PDF
NCI E-067-1997-0-JP-12 Novel Nitric Oxide-Releasing Amidine- And Enamine- Derived Diazeniumdiolates, Compositions And Uses Thereof And Method Of Making Same JP DIV 2010-050987 Abandoned
NCI E-313-2007-0-US-03 Probe and Method For Obtaining Three-Dimensional Compositional Maps of Biological Sample US National Stage 12/676,861 8941057 Abandoned PDF
NIMH E-044-1997-1-US-12 IMMUNOTOXINS FUSION PROTEINS AND MEANS FOR EXPRESSION THEREOF US DIV 12/718,673 8217158 Expired PDF
NCI E-093-2007-0-US-03 Arrays, Kits and Cancer Characterization Methods US National Stage 12/676,693 Abandoned
NCI E-190-2007-0-US-03 Pharmaceutical Compositions Containing Drugs Which Are Instable Or Sparingly Soluble In Water And Methods For Their Preparation US REEXAM 90/010,886 6407079 Expired PDF
NICHD E-001-2007-0-US-06 Conjugates Of Plasmodium Falciparum Surface Proteins As Malaria Vaccines US National Stage 12/444,963 8383133 Abandoned PDF
NHLBI E-048-2009-0-PCT-02 Cerclage Locking Device And Delivery System PCT PCT PCT/US2010/026245 Expired
NCI E-162-2010-0-US-01 Anti-HER2 IgY Antibody-functionalized Single-walled Carbon Nanotubes For Detection And Selective Destruction Of Breast Cancer Cells US 61/310,329 Abandoned
NCI E-163-2010-0-US-01 A New Method For The Construction Of Anti-HER2 IgY Antibody Functionalized Single-walled Carbon Nanotubes With Improved Properties For Detection And Selective Destruction Of Breast Cancer Cells US 61/310,324 Abandoned
NEI E-115-2010-0-US-01 Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice US 61/310,043 Abandoned
NCI E-323-2000-0-US-09 Activated Dual Specificity Lymphocytes And Their Methods of Use US CON 12/715,829 Abandoned
NCATS E-188-2009-1-US-01 Inhibitors Of Tau Protein Fibrillization. US 61/309,554 Abandoned
NCI E-266-2009-0-US-01 Development Of A Vaccine Composed Of CpG Oligonucleolides Conjugated To Apoptotic Tumor Cells To Treat Cancer. US 61/309,802 Abandoned
NIDCD E-201-2007-1-CN-04 Methods, Composition, Targets for Combinational Cancer Treatments CN National Stage 200880023062.7 Abandoned
NCI E-179-2008-0-US-02 Apelin Peptides And Methods Of Use US ORD 12/715,338 8946382 Abandoned PDF
NIDCD E-201-2007-1-JP-05 Methods, Composition, Targets for Combinational Cancer Treatments JP National Stage 2010-515267 Abandoned
NCI E-097-2010-0-US-01 UV-A Protection Factor, Or APF US 61/309,179 Abandoned